Company: BDRX
Filing Date: 2025-05-08
Form Type: POS AM
Source: 0001214659-25-007196
Chunk: 113

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-05-08
Form: POS AM
Chunk 113
---
 the selling shareholder and its affiliates owning, after exercise, a number     
 of our Ordinary Shares in excess of the beneficial ownership limitation. The amounts and percentages in the table do not give effect to       
 the 4.99% beneficial ownership limitation, if applicable. The principal business address of Ionic Ventures, LLC is 3053 Fillmore Street,      
 Suite 2565, San Francisco, CA 94123.                                                                                                          |

| (10) | The selling shareholder holds (i) warrants issued by us in                                                                                    
 prior transactions which entitle the selling shareholder to purchase an aggregate of 559,470,000 Ordinary Shares (in the form of Depositary   
 Shares), and (ii) Replacement Warrants issued by us which entitle the selling shareholder to purchase                                         
 an aggregate of 97,500,000 Ordinary Shares (in the form of Depositary Shares) and which we                                                    
 are registering hereby. The warrants are subject to a beneficial ownership limitation of 4.99%, which does not permit the selling shareholder 
 to exercise that portion of the warrants that would result in the selling shareholder and its affiliates owning, after exercise, a number     
 of our Ordinary Shares in excess of the beneficial ownership limitation. The amounts and percentages in the table do not give effect to       
 the 4.99% beneficial ownership limitation, if applicable. Richard Abbe is the managing member of Iroquois Capital Investment Group LLC.       
 Mr. Abbe has voting control and investment discretion over securities held by Iroquois Capital Investment Group LLC. As such, Mr. Abbe        
 may be deemed to be the beneficial owner (as determined under Section 13(d) of the Securities Exchange Act of 1934, as amended) of the        
 securities held by Iroquois Capital Investment Group LLC. The principal business address of Iroquois Capital Investment Group LLC is 2        
 Overhill Road, Suite 400, Scarsdale, NY 10583.                                                                                                |

| (11) | The selling shareholder holds (i) warrants issued by us in                                                                                    
 a prior transaction which entitle the selling shareholder to purchase an aggregate of 301,270,000 Ordinary Shares (in the form of Depositary  
 Shares), and (ii) Replacement Warrants issued by us which entitle the selling shareholder to purchase                                         
 an aggregate of 82,500,000 Ordinary Shares (in the form of Depositary Shares) and which we                                                    
 are registering hereby. The warrants are subject to a beneficial ownership limitation of